Coeptis Therapeutics Holdings, Inc. financial data

Symbol
COEP, COEPW on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
105 Bradford Road, Suite 420, Wexford, Pennsylvania
State of incorporation
Delaware
Fiscal year end
December 31
Former names
Bull Horn Holdings Corp. (to 10/28/2022)
Latest financial report
10-Q - Q2 2024 - Aug 16, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 51.3 % -51.4%
Debt-to-equity 1.43K % +992%
Return On Assets -373 % -156%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 39.7M shares +58%
Common Stock, Shares, Outstanding 39.7M shares +62.8%
Entity Public Float 28.8M USD -42.4%
Common Stock, Value, Issued 3.97K USD +62.8%
Weighted Average Number of Shares Outstanding, Basic 37.6M shares +72.3%
Weighted Average Number of Shares Outstanding, Diluted 37.6M shares +72.3%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 0 USD
Cost of Revenue 0 USD
Research and Development Expense 7.26M USD +1105%
Selling and Marketing Expense 5K USD +1567%
General and Administrative Expense 3.92M USD +19.2%
Operating Income (Loss) -17M USD +9.92%
Nonoperating Income (Expense) 875K USD -143%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -16.1M USD +18.3%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -16.1M USD +18.3%
Earnings Per Share, Basic -0.44 USD/shares +51.6%
Earnings Per Share, Diluted -0.44 USD/shares +51.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 13.8K USD -97.6%
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD -100%
Assets, Current 1.99M USD -47.6%
Property, Plant and Equipment, Net 10.9K USD -8.73%
Operating Lease, Right-of-Use Asset 79.1K USD +103%
Assets 4.2M USD -41.3%
Accounts Payable, Current 1.28M USD +224%
Accrued Liabilities, Current 771K USD +80.8%
Liabilities, Current 3.63M USD +19.1%
Operating Lease, Liability, Noncurrent 61.2K USD +316%
Liabilities 4.51M USD -13.2%
Retained Earnings (Accumulated Deficit) -93.4M USD -20.9%
Stockholders' Equity Attributable to Parent -443K USD -123%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -310K USD -116%
Liabilities and Equity 4.2M USD -41.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.9M USD -12.9%
Net Cash Provided by (Used in) Financing Activities 1.56M USD
Net Cash Provided by (Used in) Investing Activities -100K USD
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 39.7M shares +62.8%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.56M USD -52.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Deferred Tax Assets, Valuation Allowance 23.1M USD +23.2%
Deferred Tax Assets, Gross 23.1M USD +23.2%
Operating Lease, Liability 80.7K USD +124%
Payments to Acquire Property, Plant, and Equipment 0 USD
Lessee, Operating Lease, Liability, to be Paid 88.2K USD +114%
Property, Plant and Equipment, Gross 25.2K USD 0%
Operating Lease, Liability, Current 19.6K USD -8.07%
Lessee, Operating Lease, Liability, to be Paid, Year Two 46.1K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 22.8K USD +21.8%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 7.49K USD +42.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 19.3K USD
Deferred Tax Assets, Operating Loss Carryforwards 22.5M USD +21.9%
Preferred Stock, Shares Issued 4.3K shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Additional Paid in Capital 100M USD +26.9%
Preferred Stock, Shares Outstanding 4.3K shares
Depreciation, Depletion and Amortization 250K USD -0.04%
Interest Expense 300K USD +73.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%